Literature DB >> 1790634

Clinical and serological spectrum of systemic lupus erythematosus in Greek children.

A Siamopoulou-Mavridou1, A K Mavridis, G Dimou, A A Drosos.   

Abstract

In the present study 19 Greek Caucasian children with systemic lupus erythematosus (SLE), onset before the age of 16, were followed up for 1-12 years (mean 5.6 yrs.). Diagnosis was determined early in 14 patients and delayed by 2 to 6 years in 5. The clinical manifestations and laboratory findings did not differ significantly from those reported in adults with lupus. The major organ system involvement at onset and early course were skin and joints (80%) followed by kidneys (42%). During the course of the disease 26% of the children developed central nervous system (CNS) involvement. All the patients were treated with steroids and/or cytotoxic drugs in severe uncontrolled progressive disease. At the mean 5.6 years follow-up most patients were in remission on small doses of steroids; one patient still presents signs of active lupus nephritis and one patient died from sepsis. All the patients with CNS involvement recovered without permanent CNS residue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1790634     DOI: 10.1007/bf02208687

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

1.  Pericarditis in the rheumatologic diseases.

Authors:  A S Cohen; J J Canoso
Journal:  Cardiovasc Clin       Date:  1976

Review 2.  The natural history and response to therapy of lupus nephritis.

Authors:  E M Ginzler; A J Bollet; E A Friedman
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

3.  Systemic lupus erythematosus in childhood.

Authors:  F Caeiro; F M Michielson; R Bernstein; G R Hughes; B M Ansell
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  HLA alloantigens in Greek patients with systemic lupus erythematosus.

Authors:  A P Andonopoulos; C A Papasteriades; A A Drosos; G S Dimou; H M Moutsopoulos
Journal:  Clin Exp Rheumatol       Date:  1990 Jan-Feb       Impact factor: 4.473

6.  HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens.

Authors:  J S Smolen; J H Klippel; E Penner; M Reichlin; A D Steinberg; T M Chused; O Scherak; W Graninger; E Hartter; C C Zielinski
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

7.  Systemic lupus erythematosus in the younger patient: survival studies.

Authors:  M Abeles; J D Urman; A Weinstein; M Lowenstein; N F Rothfield
Journal:  J Rheumatol       Date:  1980 Jul-Aug       Impact factor: 4.666

8.  Central nervous system involvement in childhood systemic lupus erythematosus.

Authors:  C L Yancey; R A Doughty; B H Athreya
Journal:  Arthritis Rheum       Date:  1981-11

9.  Central nervous system manifestations in juvenile systemic lupus erythematosus: a problem of management.

Authors:  U M Davies; B M Ansell
Journal:  J Rheumatol       Date:  1988-11       Impact factor: 4.666

10.  Intermittent intravenous cyclophosphamide therapy for lupus nephritis.

Authors:  T J Lehman; D D Sherry; L Wagner-Weiner; D K McCurdy; H M Emery; D B Magilavy; A Kovalesky
Journal:  J Pediatr       Date:  1989-06       Impact factor: 4.406

View more
  2 in total

1.  Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt.

Authors:  Ashraf Bakr
Journal:  Pediatr Nephrol       Date:  2005-06-07       Impact factor: 3.714

2.  Clinical and laboratory variables of childhood systemic lupus erythematosus in western province of Saudi Arabia.

Authors:  Mohammed A Muzaffer; Sulaiman M Al-Mayouf
Journal:  Rheumatol Int       Date:  2009-11-07       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.